Related Experiment Video
Updated: Jul 15, 2026

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
Darwin: dose monitoring system applicable to various radiations with wide energy ranges
1Japan Atomic Energy Agency (JAEA), Shirakata-Shirane 2-4, Tokai-mura, Naka-gun, Ibaraki 319-1195, Japan. sato.tatsuhiko@jaea.go.jp
Abstract:
A new radiation dose monitor, designated as DARWIN (Dose monitoring system Applicable to various Radiations with Wide energy ranges), has been developed for real-time monitoring of doses in workspaces and surrounding environments of high-energy accelerator facilities. DARWIN is composed of a phoswitch-type scintillation detector, which consists of liquid organic scintillator BC501A coupled with ZnS(Ag) scintillation sheets doped with (6)Li, and a data acquisition system based on a Digital-Storage-Oscilloscope. DARWIN has the following features: (1) capable of monitoring doses from neutrons, photons and muons with energies from thermal energy to 1 GeV, 150 keV to 100 MeV and 1 MeV to 100 GeV, respectively, (2) highly sensitive with precision and (3) easy to operate with a simple graphical user-interface. The performance of DARWIN was examined experimentally in several radiation fields. The results of the experiments indicated the accuracy and wide response range of DARWIN for measuring dose rates from neutrons, photons and muons with wide energies. It was also found from the experiments that DARWIN enables us to monitor small fluctuations of neutron dose rates near the background level because of its high sensitivity. With these properties, DARWIN will be able to play a very important role for improving radiation safety in high-energy accelerator facilities.
Related Concept Videos
Biological Effects of Radiation
Radiation: Applications
The average...
Therapeutic Drug Monitoring: Drug Analysis Methods
Dose Size and Dosing Frequency: Determination Methods
Dose Response Curve: Conventional Versus Nonmonotonic
Therapeutic Drug Monitoring: Overview and Classification

